aPsoriasis Research and Treatment Center, Department of Dermatology, Venereology and Allergology and Institute of Medical Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie ...
Hidradenitis suppurativa (HS), sometimes called acne inversa, is a chronic skin condition that causes painful lesions under the skin. The lesions can look like boils or pimples, and tend to appear ...
Hidradenitis Suppurativa Market Outlook 2025-2035: The 7 major hidradenitis suppurativa market reached a value of USD 1.5 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 4.6 ...
Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help prevent tissue damage among these patients. Hidradenitis suppurativa ...
Hidradenitis suppurativa is managed with biologics like adalimumab and secukinumab, approved for moderate-to-severe cases. Adalimumab, a TNF-α inhibitor, was FDA-approved in 2015, while ...
Hidradenitis suppurativa (HS) is a chronic (long-term) inflammatory skin condition that causes painful lesions on the skin that touches other skin. These lesions can look like small, inflamed ...
Brensocatib is under clinical development by Insmed and currently in Phase I for Hidradenitis Suppurativa. According to GlobalData, Phase I drugs for Hidradenitis Suppurativa have a 91% phase ...
Remibrutinib is under clinical development by Novartis and currently in Phase II for Hidradenitis Suppurativa. According to GlobalData, Phase II drugs for Hidradenitis Suppurativa have a 44% phase ...
Opens in a new tab or window Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients with hidradenitis suppurativa, post hoc ...
USA: A recent post hoc analysis of two randomized clinical trials has provided insight into the role of C-reactive protein (CRP) as a potential biomarker for predicting the response to adalimumab in ...
A cohort study suggests that people with hidradenitis suppurativa (HS) have twice the incidence of noninfectious uveitis (NIU) as controls, an association that remained significant after adjusting ...